Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bayram, Safak (1) Beule, Dieter Dr. (3) Blüthgen, Nils (2) Burkert, Christian Martin (1) Conrad, Thomas Dr. (1) Dörr, Jan Rafael (1) Forbes, Martin Dr. (2) Henssen, Anton Prof. Dr. med. (12) Kirchner, Marieluise Dr. (1) Mastrobuoni, Guido Dr. (3) Mertins, Philipp Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Röefzaad, Claudia (2) Schwarz, Roland Dr. (2) Wolf, Jana Prof. Dr. (1) (-) Kempa, Stefan Dr. (3) 2021 (2) 2024 (1) AG Müller/Dechend (ECRC) (10) Bioinformatics and Omics Data Science (1) Cancer Genetics and Cellular Stress Responses (1) Clinical Research Unit (1) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (2) (-) Epigenetic Modifications in Neuroblastoma (3) Flow Cytometry (1) Host-microbiome factors in cardiovascular disease (6) Hypertension-caused End-Organ Damage (10) Hypertension-Mediated End-Organ Damage (10) Immune Regulation and Cancer (3) Mathematical Modelling of Cellular Processes (4) Mechanism-based Cancer Therapies (1) Molecular Biology of Peptide Hormones (1) Molecular Cardiovascular Research (2) Molecular Physiology of Somatic Sensation (2) Myology (3) Organoids (1) Protein Production and Characterization (1) Proteome Dynamics (4) Proteomics (1) Proteomics and Metabolomics (90) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) RNA Biology and Posttranscriptional Regulation (7) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (7) Translational Bioinformatics (1) Translational Cardiology and Functional Genomics (2) Tumor heterogeneity and treatment resistance in pediatric cancer (1) 3 Results: Active Filter: Kempa, Stefan Dr.Epigenetic Modifications in Neuroblastoma Sort: Result score Newest to oldest Oldest to newest March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer May 01, 2024 / Cancers L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and Signaling M. Forbes R. Kempa G. Mastrobuoni L. Rayman M. Pietzke S. Bayram B. Arlt A. Spruessel H.E. Deubzer S. Kempa
March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer
June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer
May 01, 2024 / Cancers L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and Signaling M. Forbes R. Kempa G. Mastrobuoni L. Rayman M. Pietzke S. Bayram B. Arlt A. Spruessel H.E. Deubzer S. Kempa